MedTrace Logo

An Observational Study to Assess the Burden of Drug-resistant Partial Epilepsy in Italy

NCT01332539 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 240

Last updated 2013-05-27

No results posted yet for this study

Summary

observational, non-interventional study in 120 patients with drug-resistant partial epilepsy, comprising two phases: a 3-month retrospective and a 6-month prospective. As control group, 120 patients with controlled partial epilepsy will be enrolled. The objective of the study is to describe the burden of illness in this epileptic population both in terms of costs and of quality of life. Costs and quality of life will be also compared between the two populations.

Conditions

  • Epilepsy, Partial

Interventions

OTHER

no intervention

non-interventional study

Sponsors & Collaborators

Principal Investigators

  • GSK Clinical Trials · GlaxoSmithKline

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-05-31
Primary Completion
2012-11-30
Completion
2012-11-30

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01332539 on ClinicalTrials.gov